Marti Technologies Inc. shares fall 1.09% intraday as FDA appoints new top drug regulator.

lunes, 21 de julio de 2025, 12:45 pm ET1 min de lectura
MRT--
Marti Technologies Inc. declined 1.09% in intraday trading. The FDA's appointment of George Tidmarsh as the top drug regulator, while not directly related to Marti Technologies, may have influenced investor sentiment in the broader biotech sector, potentially contributing to the stock's decline.

Marti Technologies Inc. shares fall 1.09% intraday as FDA appoints new top drug regulator.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios